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Abstract
The temperature of a malignant tumour is a universal indicator of the growth rate of the tumor. Tumor temperature
can be used as a prediction of the benefit of individual therapies and in monitoring the efficacy of breast cancer
treatment. This review provides a systematic analysis of the data available in the current literature on the role of
microwave thermometry in risk estimation, the diagnosis of breast pathology and in assessing the effect of
neoadjuvant therapy for breast cancer treatment.
Various aspects of the use of microwave thermometry in breast diseases are described: the diagnostic value of
the method and the value in differentiating hyperplasia, benign and malignant disease. Research has also
suggested a prognostic role of microwave thermometry and its possible application to assess the effect of
preoperative chemotherapy in locally advanced breast cancer.
Microwave thermometry is a non-invasive method that can provide valuable information in relation to the
diagnosis of various breast pathologies and may have value in screening programs to identify high risk groups for
subsequent diagnostics using traditional methods (ultrasound, X-ray mammography, breast MRI, morphology).
Microwave thermometry can also be used to assess the effect of ongoing neoadjuvant therapy of the primary non-
operative forms of breast cancer in order to allow early detection of response and provide as part of personalized
medicine
Keywords: Breast cancer; Microwave thermometry; Diagnostics
Introduction
Delays in diagnosis of breast cancer continue to be a problem in
clinical practice that can only be solved currently by using complex
and expensive invasive methodologies. Methods like mammography
and biopsy, unfortunately, have several disadvantages. The unavoidable
radiation dose from mammography prevents repeated screening even
in high risk groups more often than once a year. In addition,
mammography is not informative for most women younger than 35
years due to high breast density of the breast tissue. Magnetic
resonance imaging is one of the most accurate methods of diagnosis of
breast pathology, but high costs and the fact that it is a very time-
consuming method make it unsuitable for widespread use. Therefore,
the search for and introduction of novel diagnostics methods without
these limitations is one of the priorities in clinical oncology.
Microwave radiometry is a diagnostic method based on
measurement of tissue radiation in the microwave range. The intensity
of the intrinsic radiation of tissues in the 4 Gz frequency is determined
by their temperature and biophysical parameters. Unlike the well-
known infrared thermography, which measures the temperature of the
skin, microwave thermometry allows for the non-invasive detection of
thermal anomalies at a depth of several centimeters under the skin.
The first use of radiation in the microwave range for the diagnosis of
breast cancer (DBC) was proposed by the American radio astronomer
A Barrett [1]. Subsequently, scientific schools in other countries also
focused on non-invasive measurement of internal temperature [2-6].
Initially, devices measured temperature at a single point and were
called “radiothermometers”. At present, modern diagnostic complexes
like RTM-01-RES allow for the visualization of the thermal activity of
tissues, both on the surface and inside the body. When it comes to the
examination of the breast, the term "Microwave Thermography" is
commonly used, along with other terms such as microwave radiometry
technique or microwave radio thermometry. In this review, we use the
term microwave thermometry. This technology has been certified in a
number of countries, and approved as a standard of medical
diagnostics.
Literature Review
Microwave thermometry has a number of advantages compared to
other diagnostic methods. These include its non-invasiveness and the
complete absence of ionizing and other radiation. As a consequence, it
is harmless and can be used in young women. Traditional
mammography and ultrasound provide information on structural
changes: the size of the tumor, its location, the presence of
microcalcifications, etc. Microwave thermometry provides the doctor
with other data on the thermal activity of tissues, and reflects the level
of proliferation, and potentially the risk of neoplastic transformation.
In particular, this method could potentially be beneficial to aid the
identification of the following [7-10]:
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• A cancer recurrence following breast conserving surgery or
mastectomy;
• The localization of a small primary breast cancer in cases of an
edematous breast; latent forms of breast cancer in patients with
multiple metastases from an unidentified primary focus;
• The presence of tumor metastasis in regional lymph nodes;
• Breast cancer during routine screening of the high-risk patients;
• Monitoring the effectiveness of ongoing treatment for malignant
and benign breast conditions;
Over the past 10 years, multiple clinical studies have been
performed around the world on more than 1500 patients. The results
of measuring the thermal activity of tissues have been compared with
histological data (Table 1) [11].
S. No Hospital Year Sensitivity % Specificity %
1. Clinical Hospital N0 40. Moscow. Russia 1997 94.2 71.4
2.
Branch 1 Mammography clinic. Moscow.
Russia 1998 85.1 76.5
3.
Blokhin Oncological National Centre.
Moscow. Russia 1998 89.6 81.8
4. Burdenko Hospital. Moscow. Russia 2001 98 76.2
5.
Branch 1 Mammography clinic. Moscow.
Russia 2002 95.2 57.2
6. Medical College. Arkansas. USA 2003 84.8 70.2
7. Radiology Centre. Moscow. Russia 2006 96.6 56.7
8.
Blokhin Oncological National Centre.
Moscow. Russia 2013 92.1 88.3
Table 1: Clinical studies of microwave thermometry.
These studies have provided extensive experimental data to evaluate
thermal changes in breast neoplasia. In addition, experience has
accumulated on the practical use of this technology in 150 centers. The
RTM-01-RES technology was certificated for use in Russia and in
several other countries, where it is now included in the standard of
care for cancer patients [12-14].
Below, we give a theoretical explanation of the clinical experimental
data obtained in recent years.
The temperature and rate of growth of malignant tumors
Gautherie and collaborators [15,16] have studied thermal processes
in the breast for 16 years, and have tried to give answers to the
following questions:
• What determines the temperature of a malignant tumor?
• When do thermal changes in breast cancer begin?
The temperature inside the breast has been measured invasively
using thermocouples located at the end of the needle. In addition to
the internal temperature, all patients have undergone a mammogram
and measured the temperature of the skin with a thermal imager. In
total, data has been collected from 80,000 patients. The internal
temperature of 540 patients with invasive cancer has been measured.
The temperature both inside the tumor and in the surrounding tissues
has been measured. In addition, temperature measurements have been
taken at symmetrical points of the opposite breasts. After utilizing
temperature measurements using special mathematical models
Gautherie estimated the heat of tumour and the amount of energy
released by 1 cm 3 of tumor. Figure 1 shows experimental data showing
the dependence of heat emission from breast cancers related to the
doubling time (DT).
Figure 1: Metabolic heat production and growth rate of breast
carcinomas. The data was obtained by observing the progression of
small cancers in patients who initially refused treatment and in
whom a histological diagnosis was confirmed. Doubling time was
evaluated by measurements of tumor sizes on successive
mammograms, and heat production was computed by
measurements of temperature and blood flow carried out it, if it
with fine needle probes.
According to the Schwartz model, the DT is the time interval during
which the tumor doubles its volume. From Figure 1 one could see that
the heat (temperature) of malignant tumor is closely related to its DT.
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The most rapidly growing tumors with short DT have great heat
release, whereas indolent, slowly growing tumors with a long DT are
characterized by low heat release and, correspondingly, a low
temperature.
Figure 2: Kinetics of tumor development. D- Diameter of tumor in
cm.
Figure 2 shows the kinetics of tumor growth, calculated according to
the Schwartz model, depending on its heat (UW). For breast tumors
with moderate growth rate, DT is 90-100 days [17], corresponding to a
mean value of heat 30-34 mW/cm3. The preclinical phase of tumor
development is thus of the order of 7-8 years.
For "hot" tumors with a rapid growth rate (heat dissipation is 70
mW/cm3, DT- 30 days) the pre-clinical development phase is only 2
years.
It should be noted that the data obtained by Gautherie does not
contradict the general concept of increased malignant tumor
metabolism. In his famous work, Warburg [18] in 1924 found that the
basic biochemical feature of tumor cells is their ability to receive
energy from glycolysis and grow due to energy production from this
process. Respiration with the use of oxygen in cancer cells is replaced
by fermentation of glucose. For this work, he was awarded the Nobel
Prize. Cells use the anaerobic glycolysis path to dissipate significantly
more energy, which leads to an increase in temperature of tumors and
surrounding tissues.
The second important conclusion, which can be drawn from the
analysis of the data presented in Figure 1, is the correlation between
heat emissions from tumors and metastases in lymph nodes. In 18 out
of 19 patients with high heat emission, metastases were present in the
lymph nodes. However, for tumors with low thermal activity,
metastases were detected only in 5 out of 30 patients. The prognostic
potential of thermal measurement was also demonstrated by Napalkov
[19], who studied the survival of patients with breast cancer,
depending on the thermal changes on a cancer in different stages of
development. To evaluate the thermal properties, the following
classification was used:
• "Thermo-positive" are tumors with a significant increase in
temperature.
• "Thermo-negative" are tumors with no increase in temperature.
• "Burning" are tumors with a very large temperature rise (>2°C).
Figure 3 shows the survival data for patients with stage III b breast
cancer.
Figure 3: Patients survival of patient with breast cancer Stage IIIb
with burning and thermo-negative tumours.
For burning tumors, the 5-year survival was 9%, while survival for
patients with thermo-negative tumors at the same stage of
development was 6.5 times higher (60%).
The predictive potential of thermal methods was demonstrated by
studies conducted in the Center of Radiography and Radiology in 2006
[7]. These studies assessed the level of thermal changes of the tumor as
a method for classifying the degree of malignancy. The temperature
was measured non-invasively using a microwave radiometer
thermometer RTM-01-RES and was evaluated on a 6-point scale: Th1-
no thermal changes, Th5- maximum thermal changes. In 80% of
patients with a high-grade cancer, there were maximal thermal changes
(Th5). For patients with a low grade of malignancy, values of Th3
(50%) prevailed. Consequently, thermal changes correlate well with the
grade of malignancy. Grade of malignancy has been established as an
important independent predictor. According to Blamey et al. [20], 90%
of patients with a low-grade cancer live after the operation for 30 years
or more, and 90% of patients with a high-grade cancer live no more
than 8 years. Thus, information on the internal temperature of the
malignant tumor could have considerable prognostic potential.
Kinetics of thermal processes in breast cancer
The next important question is associated with the kinetics of the
thermal processes in breast cancer. When do the thermal changes
associated with malignancy occur? To answer this question Gautherie
[15,16] identified a group of 1245 patients. Mammographic screening
did not detect breast cancer (461 women were diagnosed with benign
changes, while 784 patients showed no structural changes), but there
were thermal changes. All of these patients had annual mammography
for 12 years. After 8 years, 38% of patients without structural changes
but with elevated temperature were diagnosed with breast cancer.
Among the patients found to have benign changes, this number
increased to 44% [16]. For patients with thermal changes but an
elevated temperature, this percentage was much higher for 8 years.
Thus, Gautherie showed that thermal changes precede structural ones,
which provides opportunities to identify patients of high risk. It should
be noted that the percentage of breast cancers identified as having high
temperature is much higher than that seen with mammographic
screening in asymptomatic patients. In particular, in the UK for 10
years of mammographic screening of 1000 women, breast cancer is
identified in only 36 (3.6%) women [21].
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In the studies conducted by Rozhkov et al. [7], thermal changes do
not develop when the tumor reaches a certain size, but at the stage
preceding malignant growth. Histological assessment showed that 80%
of patients presented no cancer cells, but only atypical cells. These
women already had significant thermal changes. This rise in
temperature cannot be explained by an increased metabolism of
malignant cells only, as they were not detected during histological
examination. Increasing thermal activity of tissues with proliferative
changes is known to every specialist who is engaged in microwave
thermography.
The temperature and density of the microvascular network
Japanese scientists [22] gave the first original explanation for this
phenomenon of increasing temperature. They combined invasive
temperature measurement of a malignant tumor and surrounding
tissue with measurement of microvascular network density (MVD), an
important parameter to characterize tumor angiogenesis. In Figure 4,
the vertical axis represents the increase in temperature in tissue
surrounding the tumor (dTs) and in the tissue in the non-affected
breast without tumor (dTt), compared with the temperature at
symmetric points in the opposite breast. In the horizontal axis,
microvascular network density (MVD) is the number of microvessels
in 1 cm3 of tissue surrounding the tumor. MVDc is the contralateral
breast, MVDs is the surrounding tissue. The MVD measurements were
carried out using electron microscopy.
Figure 4: Correlation between MVD and dTt, dTs. (A) MVD-dTt;
(B) MVDA.
It is clear from their experiments that dTt and dTs correlate well
with MVDc and MVDs. Thus, the internal temperature serves as an
indicator of angiogenesis. Recent years have seen a large number of
studies of MVDs in breast cancer being conducted, with numerous
studies showing that tumor growth depends on its ability to form a
new vasculature [23].
As the growth of tumor cells increases, the cancer becomes cut off
from nutrient sources necessary for survival and division. As a result,
the tumor stops growing, reaching steady-state volume (typically of the
order of 2-3 mm), at which the increase in cell mass is compensated by
cell death due to a lack of essential nutrients. Cancer may remain in
situ in this state for many years [24]. Further growth is possible only
after the induction of angiogenesis, and the growth rate of the tumor is
determined by the density of the microvascular network.
Weidner et al. [25] showed that the MVDs are directly correlated
with the incidence of metastases in a number of solid tumors. In
addition, Weidner et al. [26] found that in the area of most active
vascularization MVDs could be used as a highly significant and
independent predictor of survival in early breast cancer.
On the other hand, the MVDs study for the non-invasive disease
has been demonstrated that MVDs may serve as a clinically important
indicator for predicting the transition from in situ cancer to invasive
carcinoma [27]. A similar conclusion was reached by Cao et al. [28]
who examined the relationship between MVDs and histological
characterization of non-invasive cancer. This work established that
comedocarcinoma DCIS with a high degree of malignancy, which has
a high probability of transforming to invasive breast cancer, is
significantly associated (p <0,001) with high density of micro vessels.
Given that the temperature of the tissue surrounding a lesion correlates
with the MVDs, it is believed that non-invasive cancers with a high
potential for invasive transformation will have a high temperature. In
this regard, Rozhkova et al. [7] showed by non-invasive measurement
of internal temperature that 50% of in situ cancers have a high
temperature signal (Th 4, Th 5), despite the small size of initial
tumours.
Guinebretiere [29] has demonstrated the potential value of
microwave mammography for the detection of patients at risk. The
probability of malignancy and tumor growth depends on its ability to
form vasculature around itself. The risk of cancer was evaluated in
patients with benign breast pathology based on the density of
microvascular networks. It is known that diffuse fibrocystic disease has
a relatively low probability of malignancy. The relative risk of
malignancy (RR) in these patients is 1.9 [30]. Patients with fibrocystic
disease and high density microvascular network, the RR ranges from 7
to 11. Thus, the density of the microvascular network, and
consequently the temperature, appears to be increased at the stage
preceding malignant growth. Other researchers have shown similar
results. This opens up the opportunities for screening using microwave
thermometry, with potential to identify risk groups. Microwave
thermometry primarily identifies patients at high risk of potential
malignancies, including fast growing tumors. This method allows for
multiple readings to be performed at any time interval to continuously
monitor potential pathological changes without additional radiation
exposure for patients of all ages. Abnormalities can be detected at
depths of 3 to 7 cm, with an accuracy of 0.2 degrees in the
determination of the internal tissue temperature. In addition,
computer processing of the results enables objective evaluation of the
data [26-30].
Discussion
Comparison of microwave thermometry and traditional
mammography
The proportion of breast cancers identified between screening
rounds (called interval cancers) is an important measure of screening
effectiveness. In UK, mammographic screening is performed in
patients aged 50-70 years and more than 75% of invited women attend.
Data has shown that, of the 36 cancers diagnosed during 10 years of
screening of 1000 women, only 20 were detected during screening and
16 developed between rounds. Thus, the proportion of interval cancers
in UK is 33% of all diagnosed cancers [21]. Comparable data have
been obtained in other countries. In randomized trials in the HIP
project in New York, the proportion of interval cancers fluctuated from
19% to 36% [31]. In a Stockholm trial interval cancer varied from 25%
to 46% depending on the age group [32,33]. The 40-49 age group had a
particularly high level of interval cancers, at 65.7% [34].
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It has been shown that the combined use of X-ray and microwave
mammography can reduce the number of false negatives 3-4 times and
leads to an increased diagnostic sensitivity of 98% [9]. This is not an
unexpected result, as microwave thermography can identify fast
growing tumors and results in fewer false negatives in the 40-49 age
group. Traditional mammography, in turn, identifies cancers, "missed"
by microwave thermography (tumors with a low degree of malignancy
and low growth rate). The most recent reports in the UK and other
developed countries show a decreasing number of patients who would
like to attend regular mammography screenings [35]. Combined
diagnostics might increase patients’ confidence.
Monitoring the effectiveness of treatment of mastitis is another
interesting area of microwave thermography. Slightest changes in the
breasts are mirrored by changes in the thermal activity of breast tissue.
Thermal changes, as opposed to structural, can be seen within 10-15
days after the start of treatment. Microwave thermometry allows for an
estimation of whether the thermal activity increases due to
inflammation, proliferation and malignant growth or decreases due to
processes like fibrotic changes. In patients with fibrocystic breast
disease, thermal changes are not pronounced and do not differ from
the norm related to the age of the patient. In inflammatory or
proliferative processes, the thermal activity of tissues increases. Strong
thermal tissue changes can be seen (Th3-Th5) in 80% of patients with
atypical symptoms [7]. Microwave thermography could be used to
assess the effect of hormone therapy. It is worth acknowledging that
this is a risk-free and painless methodology that provides clear results.
Thus, it might be used in any age group, in pregnancy and in lactation.
Orinovskiy et al. [36] showed that mammography does not always
give a clear picture when evaluating the efficacy of neoadjuvant
therapy. It has been shown that microwave thermometry in patients
treated with neoadjuvant therapy can objectively evaluate its
effectiveness in 85.2% cases.
Sinelnikov et al. studied the dynamics of temperature during the
course of neoadjuvant therapy in a group of patients [37,38]. Prior to
the treatment, 100% of patients were classified in the Th5 level. After
4-6 courses of chemotherapy, 41.7% of patients had decreased to the
Th4 level, 33.3% to the Th3 level, and 25% to the Th1 level.
The dynamics of changes in temperature during the course of
chemotherapy could be detected before structural changes detected by
mammography and ultrasound, and can be used to assess the effect of
the neoadjuvant therapy as an early predictor of efficacy.
Temperature changes during neoadjuvant chemotherapy correlate
with the extent of response pathologically. Response and fibrosis is
highly correlated with temperature changes (difference between
temperature of the skin and internal temperature in healthy and tumor
breasts). Thus, these changes can be used as biomarkers of the disease
response. The overall temperature can be used to evaluate efficiency of
neoadjuvant chemotherapy.
Conclusion
At the end of the last century, infrared thermography was
recognized as insufficiently effective for practical use in breast cancer
diagnostics. At the present time, thermography cannot be a
replacement for mammography for the early diagnosis of breast cancer.
Microwave thermography is however a huge step in comparison
with the thermal imaging of the past because it allows a glimpse deep
into the breast, allowing for the evaluation of thermal changes within
the breast and on its surface.
A review of the literature has shown that microwave thermometry
can identify fast-growing tumors. It may be beneficial to include as
part of a comprehensive examination of patients with breast
pathologies and in screening programs [39]. False-negative results do
occur with slow-growing tumors, the diagnosis of which is more
accurately by traditional mammography.
Microwave thermometry allows for the evaluation of thermal
changes both at the skin surface and inside the breast tissue. Although
microwave thermometry cannot replace mammography or ultrasound
because it does not provide information on the structural changes in
the breast, it can provide additional information about the severity of
proliferative processes, manifested by thermal activity [40-44]. This
information may in many cases contribute to the development of an
optimal treatment strategy. Historical data on treated patients show the
important role of microwave thermography in developing personalized
therapeutic strategy.
Thanks to its simplicity, safety and non-invasiveness, microwave
radiometry may serve as a promising method for diagnosis, prediction
and assessment of the effectiveness of treatment of breast cancer. It
may also have potential as a method for risk stratification in breast
cancer. Among other advantages of microwave thermometry are its
availability, relatively low cost, the absence of radiation and the quick
interpretation of results.
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